MoonLake Immunotherapeutics header image

MoonLake Immunotherapeutics

MLTX

Equity

ISIN KY61559X1045 / Valor 118139749

NASDAQ (2026-06-26)

USD 19.90-0.45%

MoonLake Immunotherapeutics
UMushroom community rating:

4.00 2 votes No rating yet

NegativeNeutralPositive

About company

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory diseases. The company's primary asset is Sonelokimab, an investigational Nanobody® designed to target and treat inflammation more effectively. By leveraging advanced biotechnological approaches, MoonLake aims to improve patient outcomes in conditions characterized by chronic inflammation. The company is dedicated to advancing Sonelokimab through clinical trials to establish its efficacy and safety, positioning itself as a key player in the biopharmaceutical industry’s efforts to address unmet medical needs in inflammatory diseases.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

321%1Y

669%3Y

%5Y

Performance

70.5%1Y

76.0%3Y

87.7%5Y

Volatility

1465 M

Market cap (USD)

1,678,523

Daily traded volume (Shares)

55.19 / 52.6

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

2 votes

Performance:

4.50

Innovation:

4.00

Society:

4.00

Nature:

4.00

Alex Roberts

United Kingdom, 17 Dec 2025

Should've listened to this guy -->

Alex Roberts

United Kingdom, 20 Nov 2025

up 40% since I added a month ago, bounce back after potential lawsuit. Potential takeover looming

EQUITIES OF THE SAME SECTOR

Supermarket Income REIT PLC

Supermarket Income REIT PLC Valor: 37224350

Annual Return

-50%0%+50%

Risk level

110

0.86%GBP 0.88

JTC PLC

JTC PLC Valor: 40797286

Annual Return

-50%0%+50%

Risk level

110

-0.08%GBP 13.22

Norconsult ASA

Norconsult ASA Valor: 130537483

Annual Return

-50%0%+50%

Risk level

110

-0.14%NOK 35.00

Sirius Real Estate Limited

Sirius Real Estate Limited Valor: 3084495

Annual Return

-50%0%+50%

Risk level

110

-0.65%GBP 0.99

Shaftesbury Capital PLC

Shaftesbury Capital PLC Valor: 11114901

Annual Return

-50%0%+50%

Risk level

110

0.36%GBP 1.41

DFV Deutsche Familienversicherung AG

DFV Deutsche Familienversicherung AG Valor: 44543268

Annual Return

-50%0%+50%

Risk level

110

-7.23%EUR 7.70

Bajaj Finserv Limited

Bajaj Finserv Limited Valor: 121393835

Annual Return

-50%0%+50%

Risk level

110

-0.92%INR 1,764.15

Bank of India

Bank of India Valor: 909300

Annual Return

-50%0%+50%

Risk level

110

0.42%INR 144.70

Heliad AG

Heliad AG Valor: 2890460

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 14.15

Cantonal Bank of Saint Gall Ltd

Cantonal Bank of Saint Gall Ltd Valor: 1148406

Annual Return

-50%0%+50%

Risk level

110

1.74%CHF 642.00

SIX

FactSet

Clearbit

Logos provided by Clearbit